Reporting Our Performance

We create value for all our stakeholders and track our performance against key financial and non-financial indicators. These indicators are grouped under our main areas of engagement:

 

 

 

KPI 2015 2016 2017
Sales (Consolidated) 21.801.640 18.928.067 19.412.853 (Stand Alone)
Core operating profit 6.952.508 7.496.427 6.613.836
Core operating profit margin 31.89% 39.60% 34.07%
Net financial income 1.643.304 456.704 2.347.850
Core Earnings Per Share 0.194 0.054 0.277
Operating free cash flow -2.243.507 2.590.131 3.459.809
Operating free cash flow as % of sales -10.29% 13.68% 17.82%
Net debt (Total Liabilities) 26.577.878 24.42 25.640.488
Dividend per share USD 0.08 0.08 TBD
Dividend payments  USD 677.010 677.010 TBD
Pay-out ratio (dividend per share divided by core EPS) 8% 8% TBD
Market capitalisation 30.550.069 31.734.836 30.888.574

 

 

 Positions, Policies and Downloads:

 

Title Type Document
Quarterly Board Meeting Disclosures 31-3-2018 PDF View View
Annual Report 2016 - Mid 2017 -English & Arabic Version PDF View-English View-Arabic
Quarterly Board Meeting Disclosures 31-12-2017 PDF View
Quarterly Board Meeting Disclosures 21-11-2017 English Version PDF View
Quarterly Board Meeting Disclosures 30-9-2017 PDF View
General Management Report 21-8-2017 PDF View
Quarterly Board Meeting Disclosures 21-8-2017 PDF View View
Quarterly Board Meeting Disclosures 30-6-2017 PDF View
Quarterly Board Meeting Disclosures 31-3-2017 PDF View
Quarterly Board Meeting Disclosures 31-12-2016 PDF View
Quarterly Board Meeting Disclosures 31 - 10 - 2016 PDF View
Quarterly Board Meeting Disclosures 30-6-2016 PDF View
Quarterly Board Meeting Disclosures 31 - 3 - 2016 PDF View
Annual Report 2015 - Arabic Version PDF View
Annual Report 2014 - Arabic Version PDF View
Copy ©2024 PharmaCare, All Rights Reserved